Correlation Between Regenxbio and PepGen
Can any of the company-specific risk be diversified away by investing in both Regenxbio and PepGen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regenxbio and PepGen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regenxbio and PepGen, you can compare the effects of market volatilities on Regenxbio and PepGen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regenxbio with a short position of PepGen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regenxbio and PepGen.
Diversification Opportunities for Regenxbio and PepGen
Good diversification
The 3 months correlation between Regenxbio and PepGen is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Regenxbio and PepGen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PepGen and Regenxbio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regenxbio are associated (or correlated) with PepGen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PepGen has no effect on the direction of Regenxbio i.e., Regenxbio and PepGen go up and down completely randomly.
Pair Corralation between Regenxbio and PepGen
Given the investment horizon of 90 days Regenxbio is expected to generate 0.29 times more return on investment than PepGen. However, Regenxbio is 3.41 times less risky than PepGen. It trades about 0.05 of its potential returns per unit of risk. PepGen is currently generating about -0.04 per unit of risk. If you would invest 723.00 in Regenxbio on December 30, 2024 and sell it today you would earn a total of 60.00 from holding Regenxbio or generate 8.3% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Regenxbio vs. PepGen
Performance |
Timeline |
Regenxbio |
PepGen |
Regenxbio and PepGen Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Regenxbio and PepGen
The main advantage of trading using opposite Regenxbio and PepGen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regenxbio position performs unexpectedly, PepGen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PepGen will offset losses from the drop in PepGen's long position.Regenxbio vs. Day One Biopharmaceuticals | Regenxbio vs. Replimune Group | Regenxbio vs. Mirum Pharmaceuticals | Regenxbio vs. Rocket Pharmaceuticals |
PepGen vs. Pmv Pharmaceuticals | PepGen vs. MediciNova | PepGen vs. Pharvaris BV | PepGen vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |